Craig Kevin James 4

What Happened

• Craig Kevin James, Chief Medical Officer of AtaiBeckley Inc. (ATAI), received equity awards on January 30, 2026: 675,000 stock options and 150,000 restricted stock units (RSUs). Both grants are reported as derivative acquisitions at $0.00 per share (transaction code A).
• These awards involve no cash paid at grant. The filing does not state a fair-market dollar value for the grants.

Key Details

• Transaction date: 2026-01-30; Form 4 filed: 2026-02-03 (timely).
• Grants: 675,000 options (derivative) and 150,000 RSUs (derivative); price reported $0.00.
• Shares owned after transaction: not disclosed in the provided filing summary.
• Vesting (from footnotes):
  • Options (F1): 25% vest on January 1, 2027, then the remaining 75% vests in 36 substantially equal monthly installments thereafter.
  • RSUs (F2): 25% vest on January 1, 2027, then the remaining 75% vests in three equal annual installments on the first three anniversaries of January 1, 2027.
• Exhibit noted: Exhibit 24 (Power of Attorney).

Context

• These grants are compensation awards (code A). Options give the holder the right to buy shares in the future; RSUs convert to shares when they vest. Neither represents an immediate market purchase or sale.
• Such awards are common for executives and reflect long-term compensation tied to continued service and/or performance; they should not be interpreted on their own as a buy or sell signal.